Organigram Provides Corporate Update: Achieves #2 Market Share Over the Last Two Months

Organigram Holdings Inc., a leading licensed producer of cannabis, is pleased to provide a corporate update.

Market Share Momentum
Market share continues to be an important indicator of success for licensed producers (“LPs”) in Canada as sell through to consumers is a strong predictor of long-term sustainable revenue. Organigram is pleased to announce that it has moved into the #2 market share position in the last two months driven in large part by the success of its growing pre-roll business.¹ Market share strength has also been buoyed with strength in gummies, hash, and flower.

Category Leadership Supported by Recent Product Innovations & Launches
Organigram is pleased to announce that is has achieved a category leadership position in two growing categories: hash and gummies. The Company achieved the #1 market share position in hash globally as of November 2022 driven by innovative product launches on Tremblant, Holy Mountain and SHRED, including yet another first to market innovation, the ultra-convenient and flavourful Rip-Strips. Organigram has also secured the #1 market share position in gummies for the last two months, August and September. This impressive growth is driven by the Company’s continued success in launching new flavours and cannabinoid ratios, including THCV, under its popular SHRED’ems and Monjour gummy brands.

“Organigram is committed to maintaining its focus on being a consumer-centric and disciplined cannabis company. The success we are experiencing in these categories is a testament to our approach to investing, by making strategically sound acquisitions that are complementary to our core flower business, enabling us to capitalize on the new, growing segments in Canadian cannabis and focusing our efforts on winning in that segment,” said Beena Goldenberg, CEO of Organigram.

Exciting New Product Launches
Organigram continues its commitment to bringing high-quality cannabis products to the market that meet the evolving needs of our various consumer segments, from the price-conscious, experienced user, to the more wellness-oriented individual looking to fulfill targeted needs through cannabis.

Product Development Collaboration with BAT
Organigram and BAT continue to work together through their Product Development Collaboration (“PDC”) on new workstreams to develop innovative technologies in the edible, vape and beverage categories in addition to new disruptive inhalation formats aimed at addressing the biggest consumer pain points that exist in the category today.

Organigram is preparing to deliver new products in these spaces and the immediate launch priority includes gummies which will feature a new nano-emulsion technology, scheduled to begin commercialization in the first half of 2024.

Investment and Collaboration with U.S. Based Phylos Biosciences
Monetizing the investment in Phylos Bioscience continues to be a key focus as Organigram moves towards seed-based production in its Moncton facility. Three seed trials have already been harvested with two more nearing completion. Overall, eight F1 Hybrid cultivars are being tested with the first production scale trial room load scheduled in November 2023 and first full-scale commercial harvest planned for March 2024. Organigram is on track to convert up to 30% of harvests to seed based production by end of 2024 with Phylos investment milestones tracking towards early completion.

Moncton Facility Updates
The Company is pleased to have been designated an Energy Champion by New Brunswick Power as a result of the reduction in its environmental footprint through the conversion of 17,000 LED fixtures. With this change, Organigram’s energy footprint per room was reduced by 30%. The Company also continues to reduce its energy usage through a partnership with NB Power in the New Brunswick Strategic Energy Management Program.

Finally, Organigram commissioned its high-speed pre-roll tube-style machine in June, enabling the Company to enter the growing tube-style pre-roll joint segment with its popular SHRED and Holy Mountain brands. This investment in automated pre-roll technology has helped Organigram secure the #2 position in the category.

Lac Superiéur Facility Update
Construction at Organigram’s Lac Superiéur craft cultivation facility is now complete with the addition of four new grow rooms and an expanded packaging area. With power at the facility, equipment commissioned, and all growing, harvesting, and drying rooms being completed, Organigram is now in a position to begin growing top shelf craft quality, small batch flower out of its signature craft facility. Clones are now onsite, and Organigram expects to see the first harvest out of that facility by early December.Organigram has also finished the implementation of its new ERP system at Lac Superiéur, which is expected to provide the most up to date, accurate and timely data needed to deliver actionable business insights.

Change in Fiscal Year
As previously disclosed, Organigram has recently changed its fiscal year end to better reflect its operating and financial cycles. Organigram’s new fiscal year began on October 1, 2023, and will end on September 30, 2024. As a result, fiscal year 2023 will have 13 months and reflect the period starting September 1, 2022, and ending September 30, 2023. The Company will announce its full-year fiscal 2023 earnings in December 2023.

About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc. a licensed producer of cannabis, cannabis-derived products and cannabis infused edibles in Canada. Organigram is focused on producing high-quality, cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. 

1. Source: Adjusted market model as of Oct 4^th, 2023, based on HiFyre, Weedcrawler (QC), Board Data (NS/NB)